Clinical Trial Update: A Study of Volasertib Plus Induction Chemotherapy for Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

Phase 1 study of volasertib plus induction chemotherapy for acute myeloid leukemia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Erythroblastic Leukemia
• Megakaryoblastic Leukemia
• Monocytic Leukemia
• Myelomonocytic Leukemia

Drugs mentioned

• Volasertib (Volasertib)

Snippet

Sponsor: University of Alberta | Conditions: Leukemia, Myeloid, Acute, Leukemia, Monocytic, Acute | Phase 1 | Status: WITHDRAWN